메뉴 건너뛰기




Volumn 28, Issue 7, 2008, Pages 964-968

Treatment of radiation maculopathy with intravitreal injection of bevacizumab (Avastin)

Author keywords

Bevacizumab; Intravitreal; Macular edema; Radiation maculopathy; Vascular endothelial growth factor

Indexed keywords

BEVACIZUMAB; RUTHENIUM 106;

EID: 67649654572     PISSN: 0275004X     EISSN: None     Source Type: Journal    
DOI: 10.1097/IAE.0b013e3181706302     Document Type: Article
Times cited : (78)

References (19)
  • 1
    • 17444452702 scopus 로고    scopus 로고
    • Radiation retinopathy following plaque radiotherapy for posterior uveal melanoma
    • Gunduz K, Shields CL, Shields JA, et al. Radiation retinopathy following plaque radiotherapy for posterior uveal melanoma. Arch Ophthalmol 1999;117:609-614.
    • (1999) Arch Ophthalmol , vol.117 , pp. 609-614
    • Gunduz, K.1    Shields, C.L.2    Shields, J.A.3
  • 2
    • 0026662028 scopus 로고
    • Radiation maculopathy after proton beam irradiation for choroidal melanoma
    • Guyer DR, Mukai S, Egan KM, et al. Radiation maculopathy after proton beam irradiation for choroidal melanoma. Ophthalmology 1992;99:1278-1285.
    • (1992) Ophthalmology , vol.99 , pp. 1278-1285
    • Guyer, D.R.1    Mukai, S.2    Egan, K.M.3
  • 4
    • 0025429219 scopus 로고
    • Maculopathy caused by irradiation in patients treated for choroid melanoma
    • Haye C, Desjardins L, Bouder P, et al. Maculopathy caused by irradiation in patients treated for choroid melanoma. Ophtalmologie 1990;4:229-231.
    • (1990) Ophtalmologie , vol.4 , pp. 229-231
    • Haye, C.1    Desjardins, L.2    Bouder, P.3
  • 5
    • 0031765762 scopus 로고    scopus 로고
    • The efficacy of focal laser therapy in radiation-induced macular edema
    • Hykin PG, Shields CL, Shields JA, Arevalo JF. The efficacy of focal laser therapy in radiation-induced macular edema. Ophthalmology 1998;105:1425-1429.
    • (1998) Ophthalmology , vol.105 , pp. 1425-1429
    • Hykin, P.G.1    Shields, C.L.2    Shields, J.A.3    Arevalo, J.F.4
  • 6
    • 22744440013 scopus 로고    scopus 로고
    • Photodynamic therapy for maculopathy due to radiation retinopathy
    • Bakri SJ, Beer PM. Photodynamic therapy for maculopathy due to radiation retinopathy. Eye 2005;19:795-799.
    • (2005) Eye , vol.19 , pp. 795-799
    • Bakri, S.J.1    Beer, P.M.2
  • 7
    • 0034786579 scopus 로고    scopus 로고
    • Radiation retinopathy: The role of pentoxifylline
    • Gupta P, Meisenberg B, Amin P, Pomeranz H. Radiation retinopathy: the role of pentoxifylline. Retina 2001;21:545-547.
    • (2001) Retina , vol.21 , pp. 545-547
    • Gupta, P.1    Meisenberg, B.2    Amin, P.3    Pomeranz, H.4
  • 8
    • 0031050126 scopus 로고    scopus 로고
    • Increased expression of angiogenic growth factors in age-related maculopathy
    • Kliffen M, Sharma HS, Mooy CM, et al. Increased expression of angiogenic growth factors in age-related maculopathy. Br J Ophthalmol 1997;81:154-162.
    • (1997) Br J Ophthalmol , vol.81 , pp. 154-162
    • Kliffen, M.1    Sharma, H.S.2    Mooy, C.M.3
  • 9
    • 33644502828 scopus 로고    scopus 로고
    • Intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration
    • Avery RL, Pieramici DJ, Rabena MD, et al. Intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration. Ophthalmology 2006;113:363-372.
    • (2006) Ophthalmology , vol.113 , pp. 363-372
    • Avery, R.L.1    Pieramici, D.J.2    Rabena, M.D.3
  • 10
    • 23044505200 scopus 로고    scopus 로고
    • Optical coherence tomography findings after an intravitreal injection of bevacizumab (Avastin) for neovascular age-related macular degeneration
    • Rosenfeld PJ, Moshfeghi AA, Puliafito CA. Optical coherence tomography findings after an intravitreal injection of bevacizumab (Avastin) for neovascular age-related macular degeneration. Ophthalmic Surg Lasers Imaging 2005;36:331-335.
    • (2005) Ophthalmic Surg Lasers Imaging , vol.36 , pp. 331-335
    • Rosenfeld, P.J.1    Moshfeghi, A.A.2    Puliafito, C.A.3
  • 11
    • 33646446084 scopus 로고    scopus 로고
    • Intravitreal bevacizumab (Avastin) treatment of macular edema in central retinal vein occlusion: A short-term study
    • Iturralde D, Spaide RF, Meyerle CB, et al. Intravitreal bevacizumab (Avastin) treatment of macular edema in central retinal vein occlusion: a short-term study. Retina 2006;26:279-284.
    • (2006) Retina , vol.26 , pp. 279-284
    • Iturralde, D.1    Spaide, R.F.2    Meyerle, C.B.3
  • 12
    • 33845745774 scopus 로고    scopus 로고
    • Intravitreal bevacizumab (Avastin) therapy for persistent diffuse diabetic macular edema
    • Haritglou C, Kook D, Neubauer A, et al. Intravitreal bevacizumab (Avastin) therapy for persistent diffuse diabetic macular edema. Retina 2006;26:999-1005.
    • (2006) Retina , vol.26 , pp. 999-1005
    • Haritglou, C.1    Kook, D.2    Neubauer, A.3
  • 13
    • 33646443430 scopus 로고    scopus 로고
    • Intravitreal bevacizumab (Avastin) for refractory pseudophakic cystoid macular edema
    • Mason J, Albert M, Vail RC. Intravitreal bevacizumab (Avastin) for refractory pseudophakic cystoid macular edema. Retina 2006;26:356-357.
    • (2006) Retina , vol.26 , pp. 356-357
    • Mason, J.1    Albert, M.2    Vail, R.C.3
  • 14
    • 33846362539 scopus 로고    scopus 로고
    • Anti-VEGF bevacizumab (Avastin) for radiation optic neuropathy
    • Finger PT. Anti-VEGF bevacizumab (Avastin) for radiation optic neuropathy. Am J Ophthalmol; 2007;143:335-338.
    • (2007) Am J Ophthalmol , vol.143 , pp. 335-338
    • Finger, P.T.1
  • 15
    • 20144368709 scopus 로고    scopus 로고
    • Maximum tolerated dose of a humanized anti-vascular endothelial growth factor antibody fragment for treating neovascular age-related macular degeneration
    • Rosenfeld PJ, Schwartz SD, Blumenkranz MS, et al. Maximum tolerated dose of a humanized anti-vascular endothelial growth factor antibody fragment for treating neovascular age-related macular degeneration. Ophthalmology 2005;112:1048-1053.
    • (2005) Ophthalmology , vol.112 , pp. 1048-1053
    • Rosenfeld, P.J.1    Schwartz, S.D.2    Blumenkranz, M.S.3
  • 16
    • 34248598513 scopus 로고    scopus 로고
    • Ultrastructural findings in the primate eye after intravitreal injection of bevacizumab
    • Peters S, Heiduschka P, Julien S, et al. Ultrastructural findings in the primate eye after intravitreal injection of bevacizumab. Am J Ophthalmol 2007;143:995-1002.
    • (2007) Am J Ophthalmol , vol.143 , pp. 995-1002
    • Peters, S.1    Heiduschka, P.2    Julien, S.3
  • 17
    • 0031737671 scopus 로고    scopus 로고
    • Vascular permeability in experimental diabetes is associated with reduced endothelial occludin content: Vascular endothelial growth factor decreases occludin in retinal endothelial cells. Penn State Retina Research Group
    • Antonetti DA, Barber AJ, Khin S, et al. Vascular permeability in experimental diabetes is associated with reduced endothelial occludin content: vascular endothelial growth factor decreases occludin in retinal endothelial cells. Penn State Retina Research Group. Diabetes 1998;47:1953-1959.
    • (1998) Diabetes , vol.47 , pp. 1953-1959
    • Antonetti, D.A.1    Barber, A.J.2    Khin, S.3
  • 18
    • 33947313405 scopus 로고    scopus 로고
    • VEGF activation of protein kinase C stimulates occludin phosphorylation and contributes to endothelial permeability
    • Harhaj NS, Felinski EA, Wolepert EB, et al. VEGF activation of protein kinase C stimulates occludin phosphorylation and contributes to endothelial permeability. Invest Ophthalmol Vis Sci 2006;47:5106-5115.
    • (2006) Invest Ophthalmol Vis Sci , vol.47 , pp. 5106-5115
    • Harhaj, N.S.1    Felinski, E.A.2    Wolepert, E.B.3
  • 19
    • 34748830341 scopus 로고    scopus 로고
    • Intravitreal bevacizumab treatment for radiation macular edema after plaque radiotherapy for choroidal melanoma
    • Mason 3rd, JO Albert Jr, MA Persaud TO, Vail RS. Intravitreal bevacizumab treatment for radiation macular edema after plaque radiotherapy for choroidal melanoma. Retina 2007;27:903-907.
    • (2007) Retina , vol.27 , pp. 903-907
    • Mason 3rd, J.O.1    Albert Jr, M.A.2    Persaud, T.O.3    Vail, R.S.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.